Andrew Aromando
Chief Operating Officer at AMBRX INC
Network origin in Andrew Aromando first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.
12
| Subsidiary | Biotechnology | 12 |
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Innovex LP
 Innovex LP Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Innovex LP is a company that provides contract product development services. The company is based in Durham, NC.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Andrew Aromando via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal General Counsel | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ONCOSEC MEDICAL INCORPORATED | Medical/Nursing Services | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Vanderbilt University | College/University | Doctorate Degree | |
Bristol-Myers Squibb Holdings Ltd.
 Bristol-Myers Squibb Holdings Ltd. MiscellaneousMiscellaneous Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Holdings Ltd. is a holding British company. The company is based in Uxbridge, UK. | Miscellaneous | Corporate Officer/Principal | |
Canji, Inc.
 Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Medical/Nursing Services | Corporate Officer/Principal | |
USC Norris Comprehensive Cancer Center
 USC Norris Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services USC Norris Comprehensive Cancer Center provides cancer research, treatment, prevention and education services. Its research programs include molecular genetics, epigenetics and regulation, tumor microenvironment, cancer control, translational and clinical sciences. The firm offers direct patient care through both inpatient and outpatient services. The company was founded in 1973 and is headquartered in Los Angeles, CA. | Hospital/Nursing Management | Corporate Officer/Principal | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree Doctorate Degree | |
| Syracuse University | College/University | Graduate Degree Doctorate Degree | |
| New York University | College/University | Undergraduate Degree Graduate Degree | |
| Purdue University | College/University | Corporate Officer/Principal | |
| University of California San Diego | College/University | Doctorate Degree | |
| Vassar College | College/University | Undergraduate Degree | |
| Wheaton College (Illinois) | College/University | Undergraduate Degree | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Mid-Atlantic Diamond Ventures
 Mid-Atlantic Diamond Ventures Investment ManagersFinance Mid-Atlantic Diamond Ventures operates as an alternative investment manager. The company was founded in 2003 and is headquartered in Philadelphia, PA. | Investment Managers | Director/Board Member | |
| Schering-Plough Pharmaceuticals | Corporate Officer/Principal | ||
American Chamber of Commerce in Portugal
 American Chamber of Commerce in Portugal Miscellaneous Commercial ServicesCommercial Services The American Chamber of Commerce in Portugal is a chamber of commerce. | Miscellaneous Commercial Services | Director/Board Member | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
Alzheimer's Association Delaware Valley Chapter
 Alzheimer's Association Delaware Valley Chapter Miscellaneous Commercial ServicesCommercial Services The Alzheimer's Association Delaware Valley Chapter provides information and resources for Alzheimer's and other dementias. The non-profit company is based in Philadelphia, PA. The organization is a part of the Alzheimer's Association national site, which offers information on Alzheimer's disease and dementia symptoms, diagnosis, stages, treatment, care, and support resources. | Miscellaneous Commercial Services | Director/Board Member | |
| OTONOMY | Biotechnology | Corporate Officer/Principal | |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
| PacifiCord | Sales & Marketing | ||
Prometheus, Inc.
 Prometheus, Inc. Packaged SoftwareTechnology Services Prometheus Inc. develops algorithms and software. It specializes in applied mathematics for different applications including acoustics, antenna array design, applied probability, digital filtering, fourier analysis, optimization, pattern recognition, radar, scattering theory and signal processing. Their primary customers are government agencies and contractors. The company was founded by Marcia Byrnes in 1983 and is headquartered in Sharon, MA. | Packaged Software | Corporate Officer/Principal | |
| 4D PHARMA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GOSSAMER BIO, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| SEELOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| The Cancer Drug Development Forum | Director/Board Member | ||
83bar, Inc.
 83bar, Inc. Internet Software/ServicesTechnology Services 83bar, Inc. is a private company that specializes in patient recruitment, engagement, and journey management. The company is based in Austin, TX. The company ensures that the right patient is delivered to the right place at the right time for clinical trials and commercialization requirements. The company was founded by Sue Hrim. The CEO is Bob Baurys. | Internet Software/Services | Corporate Officer/Principal | |
Iqure Pharma, Inc.
 Iqure Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Iqure Pharma, Inc. is a biotech company that develops therapeutics for patients and physicians. The company is based in Wilmington, DE. The company was founded by Pawel Zolnierczyk, Henk de Wilde, Peter Schiemann, Anna Rzewuska. Pawel Zolnierczyk has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Ymmunobio AG
 Ymmunobio AG BiotechnologyHealth Technology Ymmunobio AG is a Swiss preclinical stage oncology biotech company that develops innovative treatments for cancer patients through new classes of antibodies. The company is based in Riehen, Switzerland. The company focuses on high unmet need indications in gastro-intestinal cancers, making extensive progress in developing first-in-class or novel class of antibodies that have the potential to overcome resistance of cancer patients to current available therapies. Ymmunobio's research is based on their deep understanding of immuno-oncology and precision cancer treatments, leveraging their profound knowledge of biologics while selecting the optimal approach to developing transformative therapeutics across cancer indications. The company was founded in 2021 by Katrin Rupalla. The CEO is Peter Schiemann. | Biotechnology | Founder | |
| Hermans International LLC | Chief Executive Officer | ||
| ZYVERSA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel |
Statistics
International
| United States | 43 |
| United Kingdom | 3 |
| Denmark | 2 |
| China | 2 |
| Portugal | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 10 |
| Health Services | 6 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operational
| Director/Board Member | 67 |
| Corporate Officer/Principal | 46 |
| Independent Dir/Board Member | 30 |
| Undergraduate Degree | 14 |
| President | 14 |
Most connected contacts
| Insiders | |
|---|---|
| Paul Maier | 25 |
| Daniel O'Connor | 22 |
| Stephen Glover | 19 |
| Jakob Dupont | 14 |
| Anthony J. Yost | 13 |
| Margaret Dalesandro | 13 |
| Katrin Rupalla | 13 |
| Sonja Nelson | 13 |
| Kate Hermans | 12 |
| Renu Vaish | 11 |
| Janet Loesberg | 8 |
| Ying Buechler | 7 |
| Edward F. Heimers | 6 |
| Xiaowei Chang | 5 |
| Janice Lu | 5 |
- Stock Market
- Insiders
- Andrew Aromando
- Company connections
